Unity Biotechnology, Inc. Share-based Payment Arrangement, Plan Modification, Incremental Cost
Unity Biotechnology, Inc. reported Share-based Payment Arrangement, Plan Modification, Incremental Cost of $300.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost · last filed 2025-03-07
- Unity Biotechnology, Inc. share-based payment arrangement, plan modification, incremental cost for fiscal 2023 was $300.00K.
- Unity Biotechnology, Inc. share-based payment arrangement, plan modification, incremental cost for fiscal 2022 was $0.00.
- Unity Biotechnology, Inc. share-based payment arrangement, plan modification, incremental cost for fiscal 2021 was $0.00.
| Period end | Share-based Payment Arrangement, Plan Modification, Incremental Cost 12 month |
|---|---|
| 2023-12-31 | $300.00K 10-K · filed 2025-03-07 |
| 2022-12-31 | $0.00 10-K · filed 2025-03-07 |
| 2021-12-31 | $0.00 10-K · filed 2024-04-15 |